Navigation Links
S*BIO Receives BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award
Date:3/5/2009

SINGAPORE, March 6 /PRNewswire/ -- S*BIO Pte Ltd today announced that it has received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. Dr. Stephen Rhind, Senior Vice President Corporate Development, S*BIO, received the award on behalf of the company, from Mr. S. Iswaran, Singapore's Senior Minister for Trade and Industry.

The Annual BioSpectrum awards recognize outstanding contributions to the growth of the biotechnology and life sciences industry in Asia. S*BIO was chosen for its innovative business model and leading position in Singapore's biotechnology industry.

"We are proud to be named Singapore's emerging bioscience company of the year," said Dr. Jan-Anders Karlsson, CEO of S*BIO. "Receiving this award not only reflects S*BIO's leading role in oncology drug discovery and development but also demonstrates the commitment of Singapore's government to the local biomedical sciences industry.

"We thank everyone at S*BIO whose combined efforts led to the significant progress we made in moving our leading candidates, the JAK2 inhibitors SB1518 and SB1578, the HDAC inhibitor SB939, and the multi-kinase inhibitor SB1317, through pre-clinical and clinical development."

About BioSpectrum

Launched in 2003 by Asia's leading specialty publishing company, CyberMedia India Ltd., BioSpectrum is India's and Asia-Pacific's most widely circulated and read Life Sciences media platform. It comes out in two monthly editions: India edition published from Banglaore and an Asian edition, printed and published from Singapore. The business-to-business magazine tracks the growth of life science companies, captures the emerging technological and entrepreneurial trends in the area of Life Sciences which include pharmaceutical, biotechnology, medical technology, bio-agriculture and bio-fuels. The combined readership of both the editions of the magazine, which is available in m
'/>"/>

SOURCE S*BIO Pte Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317
2. S*BIO Completes US$26 Million Equity Financing
3. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
4. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
5. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
6. Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility
7. Advanced Life Sciences Receives Notice of Planned Cethromycin Review by FDA Advisory Committee
8. Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair
9. Perceptive Informatics Receives Frost & Sullivan Product Line Strategy Award
10. IlluminOss Medical Receives ISO 13485 Certification
11. Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 Neurotrope, ... host a conference call to provide an update ... p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. and ... Live web cast: www.neurotropebioscience.com , under "Investor Relations"The ... after completion through September 2, 2014 at (888) ...
(Date:8/20/2014)... Toronto, Canada (PRWEB) August 20, 2014 ... wisdom that E&L studies should be performed late in ... system is known. But current regulatory trends suggest that, ... are on the rise. In recent years, multiple drug ... E&L packages or address specific questions during phase I/II. ...
(Date:8/19/2014)... (PRWEB) August 20, 2014 One ... regenerative medicine is an inadequate vascular supply. Nutrient ... and decellularized tissues is critical for successful regeneration ... attempted to mitigate deficiencies in vascularization and promote ... scaffold bioactivity, optimizing scaffold design and architecture, and ...
(Date:8/19/2014)... , Aug. 19, 2014 Research and ... Fuel Cells (SOFCs) - Global Strategic Business Report" report ... worldwide markets for Solid Oxide Fuel Cells (SOFCs) in US$ ... Canada , Europe , ... estimates and forecasts are provided for the period 2012 through ...
Breaking Biology Technology:Neurotrope To Host Conference Call 2Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2
... Tectonics Corporation,s (Amex: ETC ) ("ETC" or ... of two BARA-MED(R)XD Monoplace hyperbaric oxygen chambers in the ... state-of-the-art monoplace chambers are the first computer-controlled hyperbaric chambers ... , Hyperbaric oxygen (HBO) ...
... REYKJAVIK, Iceland, Dec. 8 deCODE genetics,(Nasdaq: ... an international consortium of,scientists from deCODE and major ... variation in the human genome (SNP) that is ... type 2 diabetes (T2D). deCODE,will employ its CLIA-registered ...
... NVAX ) today announced that the Company will hold ... human clinical trial in,healthy adult subjects of Novavax,s seasonal influenza ... 2008. , The call ... Rahul Singhvi and other members of senior management, including Chief,Medical ...
Cached Biology Technology:Environmental Tectonics Corporation Announces Placement of Two Monoplace Chambers at St. John Wound Center; First Computer-controlled Hyperbaric Chambers in Oklahoma 2Environmental Tectonics Corporation Announces Placement of Two Monoplace Chambers at St. John Wound Center; First Computer-controlled Hyperbaric Chambers in Oklahoma 3Environmental Tectonics Corporation Announces Placement of Two Monoplace Chambers at St. John Wound Center; First Computer-controlled Hyperbaric Chambers in Oklahoma 4deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service 2deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service 3deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service 4Novavax to Present Seasonal Influenza Data Results in an Investor Conference Call on December 11, 2008 2
(Date:8/21/2014)... of radiations in the 3.3 to 4.4 nanometre range, ... tissues. New theoretical findings show that it is possible ... could be the basis of an optimal technique to ... to be used in high-precision spectroscopy. Now, a new ... generate the harmonic radiationswhich are multiples of an incoming ...
(Date:8/21/2014)... successfully replicated one of the crucial steps in photosynthesis, ... which could manufacture hydrogen as a fuel. , "Water ... exciting prospect to use them to create hydrogen, and ... from the ARC Centre of Excellence for Translational Photosynthesis ... offers potential as a zero-carbon replacement for petroleum products, ...
(Date:8/20/2014)... Huntsman Cancer Institute (HCI) at the University of Utah ... that encodes BCR-ABL, the unregulated enzyme driving the blood ... Cancer Society, nearly 6,000 new cases of CML will ... called tyrosine kinase inhibitors (TKIs), target BCR-ABL and are ... CML but control it in a way that allows ...
Breaking Biology News(10 mins):Water window imaging opportunity 2Water and sunlight the formula for sustainable fuel 2Blueprint for next generation of chronic myeloid leukemia treatment 2
... cousin of the humble mustard plant, scientists at the ... big surprise while investigating how plants respond to attacks ... "Contrary to what we thought we'd find, our experiments ... concert with one another in tug-of war or teeter ...
... statistical method is a more reliable way to map ... potential cancer treatment targets, according to new Brown University ... a promising new tool for tracing human gene connections, ... other diseases. Results appeared this week in the online ...
... the humble mustard plant, scientists at the University of ... while investigating how plants respond to attacks from disease ... what we thought we'd find, our experiments showed that ... one another in tug-of war or teeter totter-fashion to ...
Cached Biology News:FDA approves more generic AIDS drugs 2FDA approves more generic AIDS drugs 3Researchers develop promising new gene network analysis method 2UNC plant researchers discover proteins interact to form hair-trigger protection against invaders 2UNC plant researchers discover proteins interact to form hair-trigger protection against invaders 3
Pancreatic Cell Cryopreservation Medium (2X) is intended for the cryopreservation of LT2 Immortalized Pancreatic Mesenchymal Cells (SCR013) and VIT1 Primary Pancreatic Mesenchymal Cells (SCR014)....
LAB/Probe Mouse-Rabbit DAB Kit...
Mouse monoclonal [SH-A1] to S100 alpha ( Abpromise for all tested applications). entrezGeneID: 6271 SwissProtID: P23297...
G-protein coupled purinergic receptor P2Y8...
Biology Products: